XML 43 R28.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share
3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share
19. Earnings Per Share
The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:
 
 
  
Three Months Ended
March 31,
 
Basic (Loss)/Earnings per Share
  
2022
 
  
2021
 
    
 
 
    
 
 
 
Net (loss)/income
   $ (10,261    $ 15,147  
Less: Income distributed to participating securities
     (549      (558
Less: Undistributed income allocable to participating securities
            (1,152
    
 
 
    
 
 
 
Net (loss)/income available to common stockholders – Basic EPS
   $ (10,810    $ 13,437  
Weighted average common shares (in thousands)
     142,782        145,649  
    
 
 
    
 
 
 
Basic (loss)/earnings per share
   $ (0.08    $ 0.09  
    
 
 
    
 
 
 

 
 
  
Three Months Ended
March 31,
 
Diluted (Loss)/Earnings per Share
  
2022
 
  
2021
 
    
 
 
    
 
 
 
Net (loss)/income available to common stockholders
   $ (10,810    $ 13,437  
Add back: Undistributed income allocable to participating securities
            1,152  
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive
            (1,152
    
 
 
    
 
 
 
Net (loss)/income available to common stockholders – Diluted EPS
   $ (10,810    $ 13,437  
    
 
 
    
 
 
 
Weighted Average Diluted Shares (in thousands):
                 
Weighted average common shares
     142,782        145,649  
Dilutive effect of common stock equivalents, excluding participating securities
            121  
    
 
 
    
 
 
 
Weighted average diluted shares, excluding participating securities (in thousands)
     142,782        145,770  
    
 
 
    
 
 
 
Diluted (loss)/earnings per share
   $ (0.08    $ 0.09  
    
 
 
    
 
 
 
Diluted (loss)/earnings per share presented above is calculated using the
two-class
method as this method results in the lowest diluted earnings per share amount for common stock. During the three months ended March 31, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive
non-participating
common stock equivalents were 509 and 149 during the three months ended March 31, 2022 and 2021, respectively (shares herein are reported in thousands).
Potential common shares associated with the conversion option embedded in the Convertible Notes were excluded from the computation for the three months ended March 31, 2022 and 2021 as the Company’s average stock price during those respective periods was lower than the conversion price.
The following table reconciles weighted average diluted shares as reported in the Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
 
 
  
Three Months Ended
March 31,
 
Reconciliation of Weighted Average Diluted Shares (in thousands)
  
2022
 
 
2021
 
Weighted average diluted shares as disclosed in the Consolidated Statements of Operations
     142,782
(1)
 
    161,831  
Less: Participating securities
                
Weighted average shares of common stock issuable upon conversion of the Preferred Shares (Note 11)
           (14,750
Potentially dilutive restricted stock awards
           (1,311
    
 
 
   
 
 
 
Weighted average diluted shares used to calculate diluted (loss)/earnings per share as disclosed in the table above
     142,782       145,770  
    
 
 
   
 
 
 
 
 
(1)
Excludes 15,521 participating securities and 31 potentially dilutive
non-participating
common stock equivalents for the three months ended March 31, 2022 as the Company reported a net loss for the period (shares herein are reported in thousands).